HK37391A - Antidepressant 1,2,4-triazolone compounds - Google Patents

Antidepressant 1,2,4-triazolone compounds Download PDF

Info

Publication number
HK37391A
HK37391A HK373/91A HK37391A HK37391A HK 37391 A HK37391 A HK 37391A HK 373/91 A HK373/91 A HK 373/91A HK 37391 A HK37391 A HK 37391A HK 37391 A HK37391 A HK 37391A
Authority
HK
Hong Kong
Prior art keywords
antidepressant
triazolone compounds
compounds
triazolone
phenoxyalkyl
Prior art date
Application number
HK373/91A
Other languages
English (en)
Inventor
E. Gammans Richard
W. Smith David
P. Yevich Joseph
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK37391(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HK37391A publication Critical patent/HK37391A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HK373/91A 1983-09-30 1991-05-16 Antidepressant 1,2,4-triazolone compounds HK37391A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds

Publications (1)

Publication Number Publication Date
HK37391A true HK37391A (en) 1991-05-24

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
HK373/91A HK37391A (en) 1983-09-30 1991-05-16 Antidepressant 1,2,4-triazolone compounds

Country Status (25)

Country Link
US (1) US4613600A (en:Method)
JP (1) JPS60100560A (en:Method)
KR (1) KR880002624B1 (en:Method)
AT (1) AT387963B (en:Method)
AU (1) AU561460B2 (en:Method)
BE (1) BE900714A (en:Method)
CA (1) CA1237723A (en:Method)
CH (1) CH661924A5 (en:Method)
CY (1) CY1541A (en:Method)
DE (1) DE3435745C2 (en:Method)
DK (1) DK169546B1 (en:Method)
ES (1) ES8601966A1 (en:Method)
FI (1) FI83310C (en:Method)
FR (1) FR2552759B1 (en:Method)
GB (1) GB2147297B (en:Method)
GR (1) GR80475B (en:Method)
HK (1) HK37391A (en:Method)
IE (1) IE58084B1 (en:Method)
IT (1) IT1178522B (en:Method)
LU (1) LU85561A1 (en:Method)
MY (1) MY102123A (en:Method)
NL (1) NL8402946A (en:Method)
SE (1) SE465928B (en:Method)
YU (1) YU45667B (en:Method)
ZA (1) ZA847589B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
JP2002541192A (ja) * 1999-04-09 2002-12-03 セプラコール， インク． Ｓ−ヒドロキシネファゾドン
AU4215300A (en) * 1999-04-09 2000-11-14 Sepracor, Inc. R-hydroxynefazodone
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
CN104208718B (zh) 2009-02-20 2017-12-29 2-Bbb医疗股份有限公司 基于谷胱甘肽的药物递送系统
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
WO2013036830A1 (en) * 2011-09-09 2013-03-14 The Board Of Trustees Of The Leland Standford Junior University Topical itraconazole formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
SE8404869L (sv) 1985-03-31
SE465928B (sv) 1991-11-18
DE3435745A1 (de) 1985-04-11
YU45667B (sh) 1992-07-20
IT8422922A0 (it) 1984-09-28
YU172184A (en) 1986-10-31
FR2552759B1 (fr) 1988-10-07
KR850002270A (ko) 1985-05-10
JPS60100560A (ja) 1985-06-04
FI83310C (fi) 1991-06-25
GR80475B (en) 1985-01-31
IT1178522B (it) 1987-09-09
BE900714A (fr) 1985-03-28
MY102123A (en) 1992-03-31
DE3435745C2 (de) 1994-11-03
ES536286A0 (es) 1985-11-16
SE8404869D0 (sv) 1984-09-28
AT387963B (de) 1989-04-10
GB2147297B (en) 1987-04-15
JPH0542435B2 (en:Method) 1993-06-28
GB2147297A (en) 1985-05-09
DK468284D0 (da) 1984-09-28
KR880002624B1 (ko) 1988-12-07
ES8601966A1 (es) 1985-11-16
NL8402946A (nl) 1985-04-16
CA1237723A (en) 1988-06-07
FR2552759A1 (fr) 1985-04-05
IE842476L (en) 1985-03-30
CH661924A5 (de) 1987-08-31
AU3364884A (en) 1985-04-04
IE58084B1 (en) 1993-06-30
AU561460B2 (en) 1987-05-07
FI843779L (fi) 1985-03-31
FI843779A0 (fi) 1984-09-26
ATA310884A (de) 1988-09-15
CY1541A (en) 1991-03-22
DK169546B1 (da) 1994-11-28
ZA847589B (en) 1985-05-29
LU85561A1 (fr) 1985-06-04
GB8424535D0 (en) 1984-11-07
FI83310B (fi) 1991-03-15
DK468284A (da) 1985-03-31
US4613600A (en) 1986-09-23

Similar Documents

Publication Publication Date Title
HK37391A (en) Antidepressant 1,2,4-triazolone compounds
TR199802691T1 (xx) Pestisid etkili 3-(ikameli fenil)-5-(tienil ya da furil)-1,2,4-triazoller
DK89595A (da) Fremgangsmåde til fremstilling af 1-(3-dimethylaminopropyl)-1'-(4-fluorphenyl)-1,3-dihydroisobenzofuran-5-carbonnitril
TR200001603T2 (tr) Yeni bileşikler
RU93052411A (ru) (-)-энантиомер-{([4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил])-гидразоно} пропандинитрил
BG101198A (en) Use of 2-[(dihydro)pyrazolyl-3'-oxymethylene]-anilides as pest-control agents and fungicides
ATE236153T1 (de) 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
ES8601923A1 (es) Procedimiento para la obtencion de n-sulfonil-n'pirimidil- y -triacinil-ureas
PL320355A1 (en) Salts of ethyl 3-(2-(4-(4-amino-imino-methyl)-phenyl)-4-methyl-2,5-diketioimidazolydinyl-1)-acetylamine)3-phenylpropionate of valuable pharmacological properties and method of obtaining them as well as pharmaceutic preparation and method of obtaining same
ATE116297T1 (de) Heterocyclische acetonitrile und ihre verwendung als fungizide.
KR960016716A (ko) 테트라졸리논
IT8421471A0 (it) Dro-1h-1,4-diazepina ad attivita'derivato di 1-[bis-(4-fluorofenil)calcio antagonista, sua preparaziometil]-4-(3-fenil-2-propenil)-esaine e composizioni che lo contengono
KR940005592A (ko) 살균제(2- 아릴- 2- 치환)에틸-1, 2, 4- 트리아졸들
ES2001809A6 (es) Un procedimiento para la preparacion de nuevas 3-(4,-fenil-piperazinil)alquil-quinazolin-2,4-(1h,3h)-dionas sustituidas
ATE307578T1 (de) Neue verwendung von (r)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylam nomethyl)-chromane und ihrer physiologisch verträglichen salze
IT8023422A0 (it) 5-(4-piridinil)-2 (1h)-piridinoni, utili come agenti cardiotonici, eloro preparazione.
KR970702275A (ko) 1-[5-메탄설폰아미도인돌릴-2-카보닐1-4-[3- -2-피리디 닐]피페라진의 신규한 결정 형태(NOVEL CRYSTAL FORMS OF 1-[5- METHANESULFONAMIDOlNDOLYL-2-CARBONYL]-4-[3-(1-METHYL- ETHYLAMINO)-2-PYRIDINYL]PIPERAZINE
ZA816489B (en) Pharmacologically active 4-(2-hydroxy-4-(substituted)phenyl)-naphthalen-2(1h)-ones and 2-ols,derivatives thereof and intermediates therefor
DK0812842T3 (da) Fremgangsmåde til fremstilling af 5-(alkoxymethyl)-2,3-pyridindicarboximidforbindelser
IL71859A (en) 3-(1,3-dioxolan-2-yl)-pyridine derivatives,their production and their use as microbicides
ATE35410T1 (de) Herstellung von 1-(3,4-dimethoxyphenylethylamino)-3-(substituie te phenoxy)-2-propanolen.
EP0232205A3 (en) Diene derivatives and vasodilators containing the same
ATE28865T1 (de) Benzoylharnstoff-verbindungen als schaedlingsbekaempfungsmittel.
EP0885610A4 (en) Tracheal smooth muscle relaxant
DE69940922D1 (de) Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-i4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20040927

PE Patent expired